Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer

NCT01006785 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to difficulty of find eligible subjects

Conditions

Breast Cancer

Interventions

DRUG: DLBS1425
DRUG: DLBS1425

Sponsor

Dexa Medica Group